AKT1 and hepatocellular carcinoma: Recently, a study conducted by Zhang et al. has demonstrated that ROS can stimulate Akt/p38 MAPK pathway directly in vitro, thereby mediating cell cycle arrest and apoptosis in human hepatoma cells [17].